AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) sold $50K-$100K of Biogen Inc. (BIIB) stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of Biogen Inc. (BIIB) stock worth $50K-$100K in a STOCK Act filing on Aug 4, 2016.
The trade happened on Jul 21, 2016, 14 days before it was made public.
BIIB has moved -22.2% since the trade date, from $282.45 to $219.88 (Oct 2, 2026 close).
- Traded
- Jul 21, 2016
- Disclosed
- Aug 4, 2016
- Filing delay
- 14 days
- Price since
- -22.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (2)
More BIIB insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.